Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.

[1]  P. Calverley,et al.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.

[2]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[3]  L. Williams,et al.  Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma , 2006, Pediatrics.

[4]  N. Barnes,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. , 2004, American journal of respiratory and critical care medicine.

[5]  B. Lipworth,et al.  Effects of treatment with formoterol on bronchoprotection against methacholine. , 1998, The American journal of medicine.

[6]  S. Newman,et al.  Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices. , 1998, Chest.

[7]  P. O'Byrne,et al.  The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs. , 1998, The Journal of allergy and clinical immunology.

[8]  D. Postma,et al.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.

[9]  F. Simons,et al.  Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. , 1997, Pediatrics.

[10]  D. Cockcroft,et al.  Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. , 1996, The Journal of allergy and clinical immunology.

[11]  D. Cockcroft,et al.  Rapid onset of tolerance to the bronchoprotective effect of salmeterol. , 1995, Chest.

[12]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[13]  S. Anderson.  Drugs and the control of exercise-induced asthma. , 1993, The European respiratory journal.

[14]  H. Magnussen,et al.  Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. , 1993, The American review of respiratory disease.

[15]  G. Anderson.  Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator. , 1993, Life sciences.

[16]  R. Pauwels,et al.  The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. , 1992, The Journal of allergy and clinical immunology.

[17]  M. Johnson,et al.  Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo , 1991, British journal of pharmacology.

[18]  P. O'Byrne,et al.  Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol. , 1991, The American review of respiratory disease.

[19]  P. O'Byrne,et al.  Tachyphylaxis to inhaled methacholine in normal but not asthmatic subjects. , 1990, Journal of applied physiology.

[20]  B. Lipworth,et al.  Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. , 1989, The American review of respiratory disease.

[21]  P. O'Byrne,et al.  Tachyphylaxis to inhaled histamine in asthmatic subjects. , 1987, Journal of applied physiology.

[22]  G. Milavetz,et al.  Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthma. , 1987, The Journal of allergy and clinical immunology.

[23]  J. Kemp,et al.  Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma. , 1985, The Journal of allergy and clinical immunology.

[24]  P. O'Byrne,et al.  Inhibition of the bronchial response to respiratory heat exchange by increasing doses of terbutaline sulphate. , 1982, Thorax.

[25]  N. Thomson,et al.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. , 1981, The Journal of allergy and clinical immunology.

[26]  F. Hargreave,et al.  Bronchial reactivity to inhaled histamine: a method and clinical survey , 1977, Clinical allergy.

[27]  J. Morris,et al.  Spirometric standards for healthy nonsmoking adults. , 2015, The American review of respiratory disease.

[28]  de VRIES,et al.  Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. , 1962, International archives of allergy and applied immunology.